Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Recruitment Status: Complete: follow-up complete"
topic_facet:"Medical Condition: Non-small cell lung cancer"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Complete%3A+follow-up+complete%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Non-small+cell+lung+cancer%22&lookfor=%22Study+Type%3A+Observational%22&type=Subject
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Complete%3A+follow-up+complete%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Non-small+cell+lung+cancer%22&lookfor=%22Study+Type%3A+Observational%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Complete%3A+follow-up+complete%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Non-small+cell+lung+cancer%22&lookfor=%22Study+Type%3A+Observational%22&type=Subject
PubPharm (50)
1
Observational study on the change of clonal heterogeneity by afatinib or gefitinib treatment using next generation sequencing analysis and the effect of osimertinib as a secondary treatment (CHASE study) : Observational study on the change of clonal heterogeneity by afatinib or gefitinib treatment using next generation sequencing analysis and the effect of osimertinib as a secondary treatment (CHASE study) - Observational study on the change of clonal heterogeneity by afatinib or gefitinib treatment using next generation sequencing analysis and the effect of osimertinib as a secondary treatment (CHASE study)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Observational study on the change of clonal heterogeneity by afatinib or gefitinib treatment using next generation sequencing analysis and the effect of osimertinib as a secondary treatment (CHASE study) : Observational study on the change of clonal heterogeneity by afatinib or gefitinib treatment using next generation sequencing analysis and the effect of osimertinib as a secondary treatment (CHASE study) - Observational study on the change of clonal heterogeneity by afatinib or gefitinib treatment using next generation sequencing analysis and the effect of osimertinib as a secondary treatment (CHASE study)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
Significance of pretreatment EGFR T790M subclones detected by droplet digital PCR on EGFR-TKI efficacy in patients with non-small cell lung cancer (PREDICT-ddPCR) - a multicenter collaborative study- (WJOG13119L) : Significance of pretreatment EGFR T790M subclones detected by droplet digital PCR on EGFR-TKI efficacy in patients with non-small cell lung cancer (PREDICT-ddPCR) - a multicenter collaborative study- - Significance of pretreatment EGFR T790M subclones detected by droplet digital PCR on EGFR-TKI efficacy - a multicenter collaborative study-
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
4
A prospective observational study of immune-checkpoint inhibitor (Nivolumab) treatment in patients with non-small cell lung cancer : A prospective observational study of immune-checkpoint inhibitor (Nivolumab) treatment in patients with non-small cell lung cancer - A prospective observational study of Nivolumab treatment
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
5
Does gefitinib prolong the survival of adenocarcinoma patients against non-adeno non-small cell lung cancer? A retrospective study. : Does gefitinib prolong the survival of adenocarcinoma patients against non-adeno non-small cell lung cancer? A retrospective study. - A retrospective survival analysis of patients in non-small cell lung cancer.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
6
Clinical performance study of a lung fusion kit : Clinical performance study of a lung fusion kit - Clinical performance study of a lung fusion kit
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
7
An immunohistochemical analysis of epithelial-to-mesenchymal transition associating molecules for the patients of pulmonary sarcomatoid carcinoma. : An immunohistochemical analysis of epithelial-to-mesenchymal transition associating molecules for the patients of pulmonary sarcomatoid carcinoma. - An immunohistochemical analysis of epithelial to mesenchymal transition associating molecules for the patients of pulmonary sarcomatoid carcinoma.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
8
Additional analysis of gene polymolphisms in the phase II study of erlotinib in previously treated advanced non-small cell lung cancer patients with carcinomatous meningitis (UMIN000007020) : Additional analysis of gene polymolphisms in the phase II study of erlotinib in previously treated advanced non-small cell lung cancer patients with carcinomatous meningitis (UMIN000007020) - Additional analysis of gene polymorphisms in phase II study of erlotinib for carcinomatous meningitis
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
9
Prospective observational results of pulmonary resection for over 75 years-old patients with non-small cell lung cancer - Multi-institutional study in Japan - : Prospective observational results of pulmonary resection for over 75 years-old patients with non-small cell lung cancer - Multi-institutional study in Japan - - Prospective observational study of pulmonary resection for elderly patients with lung cancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
10
Serum marker analysis of Erlotinib treatment in previously treated Non-small cell lung cancer (NSCLC) patients with and without Epidermal Growth Factor Receptor (EGFR) mutation (additional study of CJLSG0903/0904) : Serum marker analysis of Erlotinib treatment in previously treated Non-small cell lung cancer (NSCLC) patients with and without Epidermal Growth Factor Receptor (EGFR) mutation (additional study of CJLSG0903/0904) - Serum marker analysis of Erlotinib treatment in previously treated NSCLC patients with and without EGFR mutation
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
1
2
3
4
5
Nächster »
[5]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Recruitment Status: Complete: follow-up complete
Filter aufheben
Thema: Medical Condition: Non-small cell lung cancer
Medienart
50
Aufsätze
50
E-Artikel
50
E-Ressourcen
Zeitschriftentitel
50
WHO International Clinical Trials Registry Plat...
Thema
50
610
Medical Condition: Non-small cell lung cancer
Recruitment Status: Complete: follow-up complete
50
Study Type: Observational
2
Phase: Phase 4
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2
2023
48
2022
Erscheinungsjahr(e)
Von:
Bis:
Sprache
50
Englisch
Haven't found what you're looking for?
Wird geladen...